Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine
Go back to Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine| (NASDAQ: BNTX) | Delayed: 98.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.52 | 52 Week High | $ | |||
| Open | $98.52 | 52 Week Low | $ | |||
| Day High | $98.52 | P/E | N/A | |||
| Day Low | $98.52 | EPS | $ | |||
| Volume | 1,866 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.67 | 52 Week High | $37.39 | |||
| Open | $28.67 | 52 Week Low | $28.25 | |||
| Day High | $28.67 | P/E | 17.38 | |||
| Day Low | $28.67 | EPS | $1.65 | |||
| Volume | 101,863 | |||||
